Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2014 Volume 8 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2014 Volume 8 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis

  • Authors:
    • Xinmei Guo
    • Chunyan Wang
    • Xiaoping Wang
    • Juan Ma
    • Li Xv
    • Tingting Luan
    • Changwei Kou
  • View Affiliations / Copyright

    Affiliations: Tuberculosis Division, Shandong Chest Hospital, Jinan, Shandong 250013, P.R. China
  • Pages: 781-784
    |
    Published online on: June 24, 2014
       https://doi.org/10.3892/etm.2014.1804
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study analyzed the characteristics and risk factors associated with tracheobronchial tuberculosis (TBTB) in 410 patients with TBTB. Retrospective analysis was performed on the clinical features, bronchoscopy performance, bacteriological examination, imaging and treatment of 410 patients who were diagnosed with TBTB using bronchoscopy. Among the 410 patients, 10 patients underwent chest X‑ray which revealed two cases of atelectasis, eight cases of patch or spot shadows, three cases of cavity, one case of nodule and one case with no abnormalities. The remaining 400 patients underwent computed tomography chest scans and/or airway reconstruction examinations. Among all the lesion types, the cavity type was found to be the most likely to cause bronchial stenosis or obstruction, with statistically significant differences when compared with the congestion, stenosis or scar lesion types (P<0.01). Moreover, for the cavity type, there were 194 sites of obstruction prior to therapy; however, only 23 sites of obstruction remained following therapy. Furthermore, there were 34 sites without stenosis prior to therapy and 205 sites without stenosis following therapy. The number of sites of obstruction was significantly decreased and the number of sites without stenosis was increased upon therapy. These findings suggest that the cavity type is the most sensitive type to therapy among the five types of TBTB lesion.

Introduction

Tuberculous bronchitis is a submucosal tuberculosis mainly found in bronchial mucosa and submucosa (1,2). Tuberculous bronchitis has also been diagnosed in smooth muscle, cartilage and outer membranes; thus it is termed tracheobronchial tuberculosis (TBTB) (3). TBTB may be misdiagnosed as bronchitis, asthma, bronchiectasis or lung cancer (4,5). TBTB is present in 10%-40% of patients with active pulmonary tuberculosis (6) and the incidence of TBTB has been increasing in recent years (7). TBTB is more common in young adults than older ones, and females are more readily infected than males (8). The onset of TBTB may be concealed and its clinical manifestations are not specific, which makes the diagnosis of TBTB difficult. Clinically (9), TBTB patients may have systematic respiratory symptoms such as severe cough, sputum, wheezing, hemoptysis and paroxysmal dyspnea. In TBTB patients with stenosis in the trachea, left and right main bronchus, and middle segment of bronchus, the cough sounds like barking. In certain patients, these symptoms may also be accompanied by systematic symptoms (such as fever, night sweats, anorexia, fatigue, weight loss and irregular menstruation) and allergic manifestations (such as allergic arthritis and conjunctivitis).

In the present study, a retrospective analysis of 410 patients with TBTB was performed in order to investigate the characteristics and risk factors associated with TBTB. The patients selected for the present study were enrolled at Shandong Chest Hospital (Jinan, China) between January and December 2012.

Materials and methods

Patients

The present study was approved by the Ethics Committee of Shandong University (Jinan, China). All patients provided written informed consent. None of the patients were long-term users of hormones for the treatment of autoimmune diseases, including cancer, AIDS, diabetes, systemic lupus erythematosus and organ transplantation.

Diagnosis

All patients underwent sputum acid-fast bacilli examination (three smears and one culture using the BACTEC method), electronic bronchoscopy and a chest X-ray or computed tomography (CT) scan. According to previously described criteria (3), the 410 patients met the following criteria: i) typical lesions of TBTB identified by bronchoscopy and ii) a positive sputum smear for acid-fast bacilli and/or a positive sputum culture for Mycobacterium tuberculosis; or bronchial brushing or bronchoalveolar lavage samples positive for acid-fast bacilli; or tuberculous pathological changes identified using bronchoscopic biopsy.

Treatment

Among the 410 patients with TBTB, 382 patients were newly diagnosed. The remaining 28 cases were patients who required retreatment. The registered patients adopted the 3HRZE/6HRE program (H, isoniazid; R, rifampicin; Z, pyrazinamide; E, ethambutol). The 28 patients requiring retreatment received the 3HRZEL/6HREL program supplemented with 0.2 g isoniazid inhalation therapy. The 410 patients were treated with endobronchial injection, clamping, balloon dilatation, refrigeration and other treatments. The patients with severe airway obstruction were administered bronchoscopic therapy under general anesthesia 2–15 times. The patients were followed up for between 3 and 9 months using bronchoscopy.

Bronchoscopy and TBTB typing

The diagnosis of TBTB was performed using bronchoscopy and bacteriological or pathological analysis results. In China, TBTB is classified into six pathological types, including the inflammatory infiltration type (Fig. 1A and B), the ulceration necrosis type (Fig. 1C and D), the proliferative granulation type (Fig. 1E and F), the scar stenosis type (Fig. 1G and H), the wall softening type (Fig. 1I and J) and the lymph fistula type (Fig. 1K–M) (10).

Figure 1

The six pathological types of tracheobronchial tuberculosis. The six types consist of the (A and B) inflammatory infiltration, (C and D) ulceration necrosis, (E and F) proliferative granulation type, (G and H) scar stenosis type, (I and J) wall softening type and (K–M) lymph fistula types.

Imaging analysis

Among the 410 patients with TBTB, 10 patients received chest X-ray examination. The remaining 400 patients underwent spiral CT examination of the chest and/or airway reconstruction examinations.

Statistical analysis

SPSS software, version 21.0 (SPSS, Inc., Chicago, IL, USA) was used for the statistical analyses. Student’s t-tests and χ2 test were used for analysis of the differences between groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Characteristics of patients

The present study included 109 male and 301 female patients in the total 410 patients with TBTB (Table I). The difference (109/301) between the number of males and the females was found to be significant (t=-2.357; P<0.001). Among the patients, 10 underwent chest X-ray, revealing two cases of atelectasis, eight cases of patch or spot shadows, three cases of cavity, one case of nodule and one patient with no abnormalities. The remaining 400 patients underwent chest CT scan and/or airway reconstruction examination. The results revealed 112 cases of partial or whole left lung atelectasis, 248 cases of bronchial stenosis, 135 cases of bronchial lumen obstruction, 255 cases of patch shadows, 179 cases of spot shadows, 124 cases of cavity, 34 cases of nodules, 134 cases of hilar and mediastinal lymph node enlargment, 65 cases of hilar or mediastinal lymph node calcification and 10 patients with no abnormal alterations.

Table I

Comparison of lesion types in the 410 patients with tracheobronchial tuberculosis enrolled in the present study.

Table I

Comparison of lesion types in the 410 patients with tracheobronchial tuberculosis enrolled in the present study.

GenderTotal number of lesions, n (%)Congestion, n (%)Granulation, n (%)Cavity, n (%)Stenosis, n (%)Scar, n (%)χ2P-value
Male (n=109)111 (26.2)1 (0.2)16 (3.8)58 (13.7)29 (6.8)7 (1.7)
Female (n=301)313 (73.8)6 (1.4)33 (7.8)170 (40.1)80 (18.9)24 (5.7)
Total (n=410)424 (100)7 (1.7)49 (11.6)228 (53.8)109 (25.7)31 (7.3)1.8580.762

[i] χ2 value and the P-value were calculated through comparing the pathological lesion types between the male and the female groups.

The bronchoscopy results indicated that among the 109 male patients, there was 1 congestion lesion, 16 granulation lesions, 58 cavity lesions, 29 stenosis lesions and 7 scar lesions among the five lesion types. Among the 301 female patients, there were 6 congestion lesions, 33 granulation lesions, 170 cavity lesions, 80 stenosis lesions and 24 scar lesions. Among all the lesion types, the cavity lesion type was found to be the most likely to cause bronchial stenosis or obstruction (Table II), with statistically significant differences observed compared with the congestion, stenosis and scar lesion types (P<0.01; Table II). These findings suggest that the cavity lesion type is the predominant risk factor.

Table II

Changes in the bronchial lumen caused by tracheobronchial tuberculosis.

Table II

Changes in the bronchial lumen caused by tracheobronchial tuberculosis.

Changes in the bronchial lumen

Lesion typeNo stenosis, n (%)Stenosis, n (%)Obstruction, n (%)Total, n (%)χ2P-value
Cavity34 (5.1)228 (34.4)166 (25.1)428 (64.7)
Congestion4 (0.6)3 (0.5)0 (0)7 (1.1)21.940<0.001
Granulation8 (1.2)26 (3.9)15 (2.3)49 (7.4)4.2830.117
Stenosis0 (0)109 (16.5)38 (5.7)147 (22.2)24.976<0.001
Scar11 (1.7)18 (2.7)2 (0.3)31 (4.7)30.743<0.001
Total57 (8.6)384 (58.0)221 (33.4)662 (100)85.583<0.001

[i] χ2 value, cavity type compared with other types; P-value, cavity types compared with other types.

Comparison of the bronchoscopic therapies

The 410 patients with TBTB all received the aforementioned local treatments. There were statistically significant differences in the bronchial lumen for the granulation, cavity and congestion lesion types prior to and following therapy (P<0.01; Table III). However, there were no significant differences in bronchial lumen for the fibrous stenosis and scar lesions types prior to and following therapy, as shown in Table III. For the cavity type, there were 194 sites of obstruction prior to therapy and only 23 sites of obstruction following therapy (Table III). Furthermore, there were 34 sites without stenosis prior to therapy and 205 sites without stenosis following therapy. These results suggest that the cavity type is the most sensitive to therapy among the five lesion types. Moreover, the number of sites of obstruction was significantly decreased and the number of sites without stenosis was relatively increased following therapy.

Table III

Changes in the bronchial lumen prior to and following therapy.

Table III

Changes in the bronchial lumen prior to and following therapy.

Lesion type-Lesion number (total 424)Prior to therapyFollowing therapyχ2P-value


No stenosis, n (%)Stenosis and/or obstruction, n (%)No stenosis, n (%)Stenosis and/or obstruction, n (%)
Cavity22834 (8.0)194 (45.8)205 (48.3)23 (5.4)
Congestion74 (0.9)3 (0.7)7 (1.7)0 (0)470.000<0.001
Granulation498 (1.9)41 (9.7)44 (10.4)5 (1.2)554.0000.009
Stenosis1090 (0)109 (25.7)58 (13.7)51 (12.0)674.000<0.001
Scar3111 (2.6)20 (4.7)11 (2.6)20 (4.7)518.000<0.001

[i] χ2, cavity type compared with other types. P, cavity type compared with other types.

Discussion

In the present study, 400 patients underwent chest CT scan and/or airway reconstruction examinations, including 112 cases of partial or left whole lung atelectasis, 248 cases of bronchial stenosis and 135 cases of bronchial obstruction. X-ray examinations have no specificity for the diagnosis of TBTB (10,11). However, chest CT scans with airway reconstruction techniques are able to show stenosis and obstruction in the bronchial lumen and clearly demonstrate the extent and scope of the bronchial stenosis or obstruction, revealing the changes in the bronchial walls more clearly. In addition, using this method, it is possible to determine whether the hilar and mediastinal lymph nodes are enlarged or have calcification (6,13). Thus, CT scans with airway reconstruction techniques have clinical value for TBTB diagnosis.

In the present study, all patients underwent sputum smear microscopy three times in order to detect acid-fast bacilli and sputum culture once using the BACTEC method. There were 135 cases that were sputum smear positive and 177 cases that were sputum culture positive. All patients also underwent bronchoscopy and brushing for acid-fast bacilli sputum smear and mycobacterial culture one week following admission. There were 78 cases of patients who were acid-fast bacilli smear positive and 169 cases of patients who were brush mycobacterial culture positive among the 410 cases. There was no significant difference in the tuberculosis positive rate between the male and female patients.

TBTB is capable of invading bronchial tissue, submucosa, muscle, bronchial cartilage and outer membranes at many sites (3,14–16). Bronchiolar involvement has been found to be common in the main bronchus and upper lobe bronchus, and is more common in the left than in the right (13). In the present study, bronchoscopy revealed that among the patients with TBTB, 193 patients had lesions located in one site and 217 cases had lesions in multiple sites, predominantly in the left main bronchus (32.7%). A moderate number of lesions were observed in the left upper lobe bronchus and the lowest number was found in the right lower lobe bronchus.

Among the five types of lesion, bronchoscopy examination in the present study revealed 7 congestion lesions, 49 granulation lesions, 228 cavity lesions, 109 stenosis lesions and 31 scar lesions. Furthermore, cavity lesions were found to be significantly more common than the other types of lesions (P<0.01).

In conclusion, the incidence of TBTB is associated with gender and age. Young women usually have a higher incidence and more serious disease. Among all the types of lesions, the cavity lesion type has the highest incidence. In addition, the cavity type is more likely to cause bronchial stenosis or obstruction. Bronchoscopy is an effective means for the diagnosis and treatment of TBTB and early bronchoscopy intervention is likely to achieve better results.

Acknowledgements

This study was supported by a grant from the Medicine and Health Care Technology Development Project of Shandong Province (grant no. 2013WS0147).

References

1 

Chung HS and Lee JH: Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest. 117:385–392. 2000. View Article : Google Scholar : PubMed/NCBI

2 

Wang WB, Zhao Q, Yuan ZA, Jiang WL, Liu ML and Xu B: Deaths of tuberculosis patients in urban China: a retrospective cohort study. Int J Tuberc Lung Dis. 17:493–498. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Chinese Medical Association Tuberculosis Branch; Editorial Board of The Journal of Tuberculosis and Respiratory Disease. Tracheobronchial tuberculosis diagnosis and treatment guidelines (Trial). Chinese Journal of Tuberculosis and Respiratory Diseases. 35:581–587. 2012.(In Chinese).

4 

Ehrlich RI, Adams S, Baatjies R and Jeebhay MF: Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 15:886–891. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Watanabe A: Clinical manifestation of Q fever and tuberculosis, similarly caused by intracellular parasites. Kekkaku. 81:543–549. 2006.(In Japanese).

6 

Kashyap S, Mohapatra PR and Saini V: Endobronchial tuberculosis. Indian J Chest Dis Allied Sci. 45:247–256. 2003.

7 

Xue Q, Wang N, Xue X and Wang J: Endobronchial tuberculosis: an overview. Eur J Clin Microbiol Infect Dis. 30:1039–1044. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Rikimaru T: Endobronchial tubereulosis. Expert Rev Anti Infect Ther. 2:245–251. 2004. View Article : Google Scholar

9 

He RX and Zhao SY: Analysis of clinical manifestations and diagnosis of 102 children with bronchial tuberculosis. Zhonghua Er Ke Za Zhi. 50:737–739. 2012.(In Chinese).

10 

Tang SJ, Xiao HP, Hu HL, et al: Clinical characteristic, diagnostic standard and types of endobronchial tuberculosis: An analysis of 278 cases. Chinese Journal of Clinicians (Electronic Edition). 3:32–40. 2009.(In Chinese).

11 

Jung SW, Kim MW, Cho SK, et al: A case of endobronchial aspergilloma associated with foreign body in immunocompetent patient without underlying lung disease. Tuberc Respir Dis (Seoul). 74:231–234. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Verma A, Park HY, Lim SY, et al: Posttuberculosis tracheobronchial stenosis: use of CT to optimize the time of silicone stent removal. Radiology. 263:562–568. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Zhu XH, Shao J, You ZQ, et al: The diagnostic value of multi-slice spiral CT in endobronchial tuberculosis. Chinese Journal of Radiology. 38:26–29. 2004.(In Chinese).

14 

Jiang HN, Zuo JM and He LX: The diagnosis and therapy advancement of tracheo-bronchial tuberculosis. Bulletin of the Chinese Antituberculosis Association. 22:50–54. 2000.(In Chinese).

15 

Iwamoto Y, Miyazawa T, Kurimoto N, et al: Interventional bronchoscopy in the management of airway stenosis due to tracheobronchial tuberculosis. Chest. 126:1344–1352. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Chhajed PN, Malouf MA and Glanville AR: Bronchoscopic dilatation in the management of benign (non-transplant) tracheobronchial stenosis. Intern Med J. 31:512–516. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guo X, Wang C, Wang X, Ma J, Xv L, Luan T and Kou C: Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis. Exp Ther Med 8: 781-784, 2014.
APA
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., & Kou, C. (2014). Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis. Experimental and Therapeutic Medicine, 8, 781-784. https://doi.org/10.3892/etm.2014.1804
MLA
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., Kou, C."Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 8.3 (2014): 781-784.
Chicago
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., Kou, C."Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 8, no. 3 (2014): 781-784. https://doi.org/10.3892/etm.2014.1804
Copy and paste a formatted citation
x
Spandidos Publications style
Guo X, Wang C, Wang X, Ma J, Xv L, Luan T and Kou C: Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis. Exp Ther Med 8: 781-784, 2014.
APA
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., & Kou, C. (2014). Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis. Experimental and Therapeutic Medicine, 8, 781-784. https://doi.org/10.3892/etm.2014.1804
MLA
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., Kou, C."Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 8.3 (2014): 781-784.
Chicago
Guo, X., Wang, C., Wang, X., Ma, J., Xv, L., Luan, T., Kou, C."Characteristics and risk factor analysis of 410 cases of tracheobronchial tuberculosis". Experimental and Therapeutic Medicine 8, no. 3 (2014): 781-784. https://doi.org/10.3892/etm.2014.1804
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team